Labeler
Zydus Lifesciences Limited NDC Codes
Zydus Lifesciences Limited lists 661 finished drug products in the FDA NDC Directory under NDC labeler codes 65841, 70771.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Selexipag, Isotretinoin, dasatinib, brivaracetam, tofacitinib, Diltiazem hydrochloride, Eltrombopag, Ascorbic acid, Verapamil hydrochloride, gabapentin, oxcarbazepine, sacubitril and valsartan, minocycline hydrochloride, Zituvimet XR, Sitagliptin and Metformin Hydrochloride
- Active ingredients
- Selexipag, Isotretinoin, Dasatinib, Sitagliptin, Metformin hydrochloride, Brivaracetam, Valsartan, Tofacitinib citrate, Diltiazem hydrochloride, Eltrombopag olamine, Ascorbic acid, Verapamil hydrochloride
- NDC labeler codes
- 65841, 70771
- Strengths (from the 100 most recently listed products)
- Sitagliptin 50 mg/1; Metformin hydrochloride 1000 mg/1; Ascorbic acid 500 mg/mL; Metformin hydrochloride 500 mg/1; Sitagliptin 100 mg/1; Tretinoin .25 mg/g; Fluvoxamine maleate 100 mg/1; Fluvoxamine maleate 150 mg/1; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Tofacitinib citrate 10 mg/1; Fluorescein sodium 100 mg/mL; Fluorescein sodium 250 mg/mL; Diltiazem hydrochloride 30 mg/1; Diltiazem hydrochloride 60 mg/1; Diltiazem hydrochloride 90 mg/1; Diltiazem hydrochloride 120 mg/1; Verapamil hydrochloride 120 mg/1; Verapamil hydrochloride 180 mg/1; Verapamil hydrochloride 240 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Capsule, Tablet, Film coated, Extended release, Injection, Kit, Injection, Solution, Tablet, Extended release, Cream, Capsule, Extended release, Tablet, For suspension, Gel, Powder, For solution, Shampoo, Injection, Powder, Lyophilized, For solution, Capsule, Coated pellets, Patch, Extended release
- Routes
- Oral, Intravenous, Topical, Intramuscular, Subcutaneous, Transdermal
- Drug classes (FDA established)
- Prostacyclin Receptor Agonist, Retinoid, Calcium Channel Blocker, Serotonin Reuptake Inhibitor, Kinase Inhibitor, Biguanide, Dipeptidyl Peptidase 4 Inhibitor, Angiotensin 2 Receptor Blocker, Janus Kinase Inhibitor, Thrombopoietin Receptor Agonist, Anti-epileptic Agent, Vitamin C, Neprilysin Inhibitor, Tetracycline-class Drug, Diagnostic Dye, Sodium-Glucose Cotransporter 2 Inhibitor, Sulfone, Serotonin-4 Receptor Agonist, Amide Local Anesthetic, Corticosteroid, Cholinergic Receptor Agonist, Calcitonin, Oxidation-Reduction Agent, Antiparasitic, Pediculicide, Endothelin Receptor Antagonist, Nitroimidazole Antimicrobial, Xanthine Oxidase Inhibitor, Histamine-2 Receptor Antagonist, Nonsteroidal Anti-inflammatory Drug, Azole Antifungal, Antiarrhythmic, l-Thyroxine, Anticholinergic
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 173 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Nortriptyline Hydrochloride | Nortriptyline hydrochloride 25 mg/1 | CapsuleOral | 70771-1613 | 70771-1613-0170771-1613-0370771-1613-05 | — |
| Nortriptyline Hydrochloride | Nortriptyline hydrochloride 50 mg/1 | CapsuleOral | 70771-1614 | 70771-1614-0170771-1614-0370771-1614-05 | — |
| Nortriptyline Hydrochloride | Nortriptyline hydrochloride 75 mg/1 | CapsuleOral | 70771-1615 | 70771-1615-0170771-1615-0370771-1615-05 | — |
| Potassium Chloride | Potassium chloride 750 mg/1 | Tablet, Extended releaseOral | 70771-1599 | 70771-1599-0070771-1599-01 | — |
| Potassium Chloride | Potassium chloride 1500 mg/1 | Tablet, Extended releaseOral | 70771-1600 | 70771-1600-0070771-1600-0170771-1600-05 | — |
| Propafenone Hydrochloride | Propafenone hydrochloride 225 mg/1 | Capsule, Extended releaseOral | 70771-1525 | 70771-1525-0570771-1525-06 | — |
| Propafenone Hydrochloride | Propafenone hydrochloride 325 mg/1 | Capsule, Extended releaseOral | 70771-1526 | 70771-1526-0570771-1526-06 | — |
| Propafenone Hydrochloride | Propafenone hydrochloride 425 mg/1 | Capsule, Extended releaseOral | 70771-1527 | 70771-1527-0570771-1527-06 | — |
| vigabatrin | Vigabatrin 500 mg/1 | Tablet, Film coatedOral | 70771-1654 | 70771-1654-01 | — |
| Fulvestrant | Fulvestrant 50 mg/mL | Injection, SolutionIntramuscular | 70771-1626 | 70771-1626-08 | — |
| Nelarabine | Nelarabine 5 mg/mL | InjectionIntravenous | 70771-1685 | 70771-1685-0170771-1685-08 | — |
| Nystatin | Nystatin 100000 [USP'U]/g | PowderTopical | 70771-1585 | 70771-1585-0170771-1585-0270771-1585-03 | — |
| Mesalamine | Mesalamine .375 g/1 | Capsule, Extended releaseOral | 70771-1625 | 70771-1625-07 | — |
| Oseltamivir Phosphateoseltamivir acid | Oseltamivir phosphate 6 mg/mL | SuspensionOral | 70771-1598 | 70771-1598-06 | — |
| Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine 100 mg/1; Tenofovir disoproxil fumarate 150 mg/1 | Tablet, Film coatedOral | 70771-1620 | 70771-1620-0370771-1620-0470771-1620-09 | — |
| Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine 133 mg/1; Tenofovir disoproxil fumarate 200 mg/1 | Tablet, Film coatedOral | 70771-1621 | 70771-1621-0370771-1621-0470771-1621-09 | — |
| Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine 167 mg/1; Tenofovir disoproxil fumarate 250 mg/1 | Tablet, Film coatedOral | 70771-1622 | 70771-1622-0370771-1622-0470771-1622-09 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 1 mg/1 | Tablet, Film coatedOral | 70771-1581 | 70771-1581-0170771-1581-05 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 2.5 mg/1 | Tablet, Film coatedOral | 70771-1582 | 70771-1582-0170771-1582-05 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 5 mg/1 | Tablet, Film coatedOral | 70771-1583 | 70771-1583-0170771-1583-05 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 10 mg/1 | Tablet, Film coatedOral | 70771-1584 | 70771-1584-0170771-1584-05 | — |
| Colchicine | Colchiceine .3 mg/1 | TabletOral | 70771-1590 | 70771-1590-0170771-1590-0370771-1590-05+1 more | — |
| Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine 200 mg/1; Tenofovir disoproxil fumarate 300 mg/1 | Tablet, Film coatedOral | 70771-1709 | 70771-1709-0370771-1709-0470771-1709-09 | — |
| Droxidopa | Droxidopa 100 mg/1 | CapsuleOral | 70771-1609 | 70771-1609-09 | — |
| Droxidopa | Droxidopa 200 mg/1 | CapsuleOral | 70771-1610 | 70771-1610-09 | — |
| Droxidopa | Droxidopa 300 mg/1 | CapsuleOral | 70771-1611 | 70771-1611-09 | — |
| Liothyronine sodium | Liothyronine sodium 5 ug/1 | TabletOral | 70771-1606 | 70771-1606-0070771-1606-01 | — |
| Liothyronine sodium | Liothyronine sodium 25 ug/1 | TabletOral | 70771-1607 | 70771-1607-0070771-1607-01 | — |
| Liothyronine sodium | Liothyronine sodium 50 ug/1 | TabletOral | 70771-1608 | 70771-1608-0070771-1608-01 | — |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | 70771-1524 | 70771-1524-01 | — |
| Meclizine Hydrochloride | Meclizine hydrochloride 12.5 mg/1 | TabletOral | 70771-1539 | 70771-1539-0070771-1539-0170771-1539-03+2 more | — |
| Meclizine Hydrochloride | Meclizine hydrochloride 25 mg/1 | TabletOral | 70771-1540 | 70771-1540-0070771-1540-0170771-1540-03+2 more | — |
| Albuterol | Albuterol sulfate 2 mg/1 | TabletOral | 70771-1511 | 70771-1511-01 | — |
| Albuterol | Albuterol sulfate 4 mg/1 | TabletOral | 70771-1512 | 70771-1512-0170771-1512-05 | — |
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | Injection, SolutionIntravenous | 70771-1601 | 70771-1601-07 | — |
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | Injection, SolutionIntravenous | 70771-1602 | 70771-1602-05 | — |
| dimethyl fumarate | Dimethyl fumarate 120 mg/1 | Capsule, Delayed releaseOral | 70771-1530 | 70771-1530-07 | — |
| dimethyl fumarate | Dimethyl fumarate 240 mg/1 | Capsule, Delayed releaseOral | 70771-1531 | 70771-1531-0670771-1531-08 | — |
| Sevelamer carbonate | Sevelamer carbonate 800 mg/1 | Tablet, Film coatedOral | 70771-1520 | 70771-1520-0070771-1520-0470771-1520-08 | — |
| Midodrine hydrochloride | Midodrine hydrochloride 2.5 mg/1 | TabletOral | 70771-1595 | 70771-1595-01 | — |
| Midodrine hydrochloride | Midodrine hydrochloride 5 mg/1 | TabletOral | 70771-1596 | 70771-1596-01 | — |
| Midodrine hydrochloride | Midodrine hydrochloride 10 mg/1 | TabletOral | 70771-1597 | 70771-1597-01 | — |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injectable, LiposomalIntravenous | 49315-008 | 49315-0008-03 | — |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injectable, LiposomalIntravenous | 49315-009 | 49315-0009-07 | — |
| betamethasone dipropionate | Betamethasone dipropionate .5 mg/g | OintmentTopical | 70771-1550 | 70771-1550-0170771-1550-04 | — |
| perphenazine | Perphenazine 2 mg/1 | TabletOral | 70771-1041 | 70771-1041-0170771-1041-0470771-1041-05 | — |
| perphenazine | Perphenazine 4 mg/1 | TabletOral | 70771-1042 | 70771-1042-0170771-1042-0470771-1042-05 | — |
| perphenazine | Perphenazine 8 mg/1 | TabletOral | 70771-1043 | 70771-1043-0170771-1043-0470771-1043-05 | — |
| perphenazine | Perphenazine 16 mg/1 | TabletOral | 70771-1044 | 70771-1044-0170771-1044-0470771-1044-05 | — |
| deferasirox | Deferasirox 180 mg/1 | Tablet, Film coatedOral | 70771-1472 | 70771-1472-0170771-1472-03 | — |
Zydus Lifesciences Limited: common questions
- What is Zydus Lifesciences Limited's NDC labeler code?
- 65841, 70771. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Zydus Lifesciences Limited?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.